HAE.F - HAEMATO AG

Frankfurt - Frankfurt Delayed Price. Currency in EUR

HAEMATO AG

Lilienthalstrasse 5c
Schonefeld 12529
Germany
49 30 897 30 86 70
http://www.haemato.ag

Sector
Industry
Full Time Employees171

Key Executives

NameTitlePayExercisedYear Born
Mr. Uwe ZimdarsCEO & Member of the Exec. BoardN/AN/AN/A
Mr. Daniel KrachtCFO & Member of the Exec. BoardN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European import medicinal products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and commercializes pharmaceutical, medicinal, and medical engineering products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors and hospitals. The company was founded in 1993 and is based in Schönefeld, Germany. HAEMATO AG is a subsidiary of MPH Health Care AG.

Corporate Governance

HAEMATO AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.